Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
April-2023 Volume 18 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2023 Volume 18 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells

  • Authors:
    • Kentaro Ohuchi
    • Ryo Saga
    • Kazuki Hasegawa
    • Eichi Tsuruga
    • Yoichiro Hosokawa
    • Manabu Fukumoto
    • Kazuhiko Okumura
  • View Affiliations / Copyright

    Affiliations: Division of Reconstructive Surgery for Oral and Maxillofacial Region, Department of Human Biology and Pathophysiology, School of Dentistry, Health Sciences University of Hokkaido, Tobetsu‑cho, Ishikari‑gun, Hokkaido 061‑0293, Japan, Department of Radiation Science, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036‑8564, Japan, Pathology Informatics Team, RIKEN Center for Advanced Intelligence Project, Chuo‑ku, Tokyo 103‑0027, Japan
  • Article Number: 28
    |
    Published online on: February 24, 2023
       https://doi.org/10.3892/br.2023.1610
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Radioresistant cancer cells lead to poor prognosis after radiotherapy. However, the mechanisms underlying cancer cell radioresistance have not been fully elucidated. Thus, the DNA damage response of clinically relevant radioresistant oral squamous cell carcinoma HSC2‑R cells, established by long‑term exposure of parental HSC2 cells to fractionated radiation, was investigated. The DNA double‑strand break (DSB) repair protein‑specific inhibitor, NU7441, which targets DNA‑dependent protein kinase catalytic subunit (DNA‑PKcs) phosphorylation, and IBR2, which targets Rad51, were administered to HSC2 and HSC2‑R cells. NU7441 administration eliminated colony formation in both cell lines under 6 Gy X‑ray irradiation, whereas IBR2 did not affect colony formation. NU7441 and IBR2 significantly enhanced 6 Gy X‑ray irradiation‑induced apoptosis in HSC2‑R cells. In HSC2‑R cells, cell cycle arrest released earlier than in HSC2 cells, and phosphorylated‑H2A histone family member X (γH2AX) expression rapidly decreased. Following NU7441 administration, γH2AX expression and the cell percentages of the G2/M phase were not decreased at 48 h after treatment in HSC2‑R cells. DNA‑PKcs has been demonstrated to regulate non‑homologous end‑joining (NHEJ) and homologous recombination (HR) repair, and the later phase of DSB repair is dominated by HR. Therefore, the results of the present study indicated that the DSB repair mechanism in HSC2‑R cells strongly depends on NHEJ and loss of HR repair function. The present study revealed a potential mechanism underlying the acquired radioresistance and therapeutic targets in radioresistant cancer cells.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TY, et al: Expanding global access to radiotherapy. Lancet Oncol. 16:1153–1186. 2015.PubMed/NCBI View Article : Google Scholar

2 

Olivares-Urbano MA, Griñán-Lisón C, Marchal JA and Núñez MI: CSC Radioresistance: A therapeutic challenge to improve radiotherapy effectiveness in cancer. Cells. 9(1651)2020.PubMed/NCBI View Article : Google Scholar

3 

Bajinskis A, Natarajan AT, Erixon K and Harms-Ringdahl M: DNA double strand breaks induced by the indirect effect of radiation are more efficiently repaired by non-homologous end joining compared to homologous recombination repair. Mutat Res. 756:21–29. 2013.PubMed/NCBI View Article : Google Scholar

4 

Vignard J, Mirey G and Salles B: Ionizing-radiation induced DNA double strand breaks: A direct and indirect lighting up. Radiother Oncol. 108:362–369. 2013.PubMed/NCBI View Article : Google Scholar

5 

Hawkins RB and Inaniwa T: A microdosimetric-kinetic model for cell killing by protracted continuous irradiation including dependence on LET I: Repair in cultured mammalian cells. Radiat Res. 180:584–594. 2013.PubMed/NCBI View Article : Google Scholar

6 

Matsuya Y, McMahon SJ, Tsutsumi K, Sasaki K, Okuyama G, Yoshii Y, Mori R, Oikawa J, Prise KM and Date H: Investigation of dose-rate effects and cell-cycle distribution under protracted exposure to ionizing radiation for various dose-rates. Sci Rep. 8(8287)2018.PubMed/NCBI View Article : Google Scholar

7 

Qi XS, Pajonk F, McCloskey S, Low DA, Kupelian P, Steinberg M and Sheng K: Radioresistance of the breast tumor is highly correlated to its level of cancer stem cell and its clinical implication for breast irradiation. Radiother Oncol. 124:455–461. 2017.PubMed/NCBI View Article : Google Scholar

8 

Matsuya Y, McMahon SJ, Butterworth KT, Naijo S, Nara I, Yachi Y, Saga R, Ishikawa M, Sato T, Date H and Prise KM: Oxygen enhancement ratios of cancer cells after exposure to intensity modulated X-ray fields: DNA damage and cell survival. Phys Med Biol. 66:2021.PubMed/NCBI View Article : Google Scholar

9 

Kim RK, Suh Y, Cui YH, Hwang E, Lim EJ, Yoo KC, Lee GH, Yi JM, Kang SG and Lee SJ: Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells. Cancer Sci. 104:1172–1177. 2013.PubMed/NCBI View Article : Google Scholar

10 

Fukui R, Saga R, Matsuya Y, Tomita K, Kuwahara Y, Ohuchi K, Sato T, Okumura K, Date H, Fukumoto M and Hosokawa Y: Tumor radioresistance caused by radiation-induced changes of stem-like cell content and sub-lethal damage repair capability. Sci Rep. 12(1056)2022.PubMed/NCBI View Article : Google Scholar

11 

Saga R, Matsuya Y, Takahashi R, Hasegawa K, Date H and Hosokawa Y: Analysis of the high-dose-range radioresistance of prostate cancer cells, including cancer stem calls, based on a stochastic model. J Radiat Res. 60:298–307. 2019.PubMed/NCBI View Article : Google Scholar

12 

Murata K, Saga R, Monzen S, Tsuruga E, Hasegawa K and Hosokawa Y: Understanding the mechanism underlying the acquisition of radioresistance in human prostate cancer cells. Oncol Lett. 17:5830–5838. 2019.PubMed/NCBI View Article : Google Scholar

13 

Shibata A: Regulation of repair pathway choice at two-ended DNA double-strand breaks. Mutat Res. 803-805:51–55. 2017.PubMed/NCBI View Article : Google Scholar

14 

Shibata A and Jeggo PA: DNA double-stand break repair in a cellular context. Clin Oncol (R Coll Radiol). 26:243–249. 2014.PubMed/NCBI View Article : Google Scholar

15 

Karanam K, Kafri R, Loewer A and Lahav G: Quantitative live cell imaging reveals a gradual shift between DNA repair mechanisms and a maximal use of HR in mid S phase. Mol Cell. 47:320–329. 2012.PubMed/NCBI View Article : Google Scholar

16 

Wang Y, Xu H, Liu T, Huang M, Butter PP, Li C, Zhang L, Kao GD, Gong Y, Maity A, et al: Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells. JCI insight. 3(e98096)2018.PubMed/NCBI View Article : Google Scholar

17 

Kuwahara Y, Mori M, Oikawa T, Shimura T, Ohtake Y, Mori S, Ohkubo Y and Fukumoto M: The modified high-density survival assay is the useful tool to predict the effectiveness of fractionated radiation exposure. J Radiat Res. 51:297–302. 2010.PubMed/NCBI View Article : Google Scholar

18 

Kuwahara Y, Roudkenar MH, Urushihara Y, Saito Y, Tomita K, Roushandeh AM, Sato T, Kurimasa A and Fukumoto M: Clinically relevant radioresistant cell line: A simple model to understand cancer radioresistance. Med Mol Morphol. 50:195–204. 2017.PubMed/NCBI View Article : Google Scholar

19 

Liston DR and Davis M: Clinically relevant concentrations of anticancer drugs: A guide for nonclinical studies. Clin Cancer Res. 23:3489–3498. 2017.PubMed/NCBI View Article : Google Scholar

20 

Huang X, Okafuji M, Traganos F, Luther E, Holden E and Darzynkiewicz Z: Assessment of histone H2AX phosphorylation induced by DNA topoisomerase Ⅰ and Ⅱ inhibitors topotecan and mitoxantrone and by the DNA corss-linking agent cisplatin. Cytometry A. 58:99–110. 2004.PubMed/NCBI View Article : Google Scholar

21 

Difilippantonio MJ, Zhu J, Chen HT, Meffre E, Nussenzweig MC, Max EE, Ried T and Nussenzweig A: DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature. 404:510–514. 2000.PubMed/NCBI View Article : Google Scholar

22 

Tachon G, Cortes U, Guichet PO, Rivet P, Balbous A, Masliantsev K, Berger A, Boissonnade O, Wager M and Karayan-Tapon L: Cell cycle changes after glioblastoma stem cell irradiation: The major role of RAD51. Int J Mol Sci. 19(3018)2018.PubMed/NCBI View Article : Google Scholar

23 

Wurster S, Hennes F, Parplys AC, Seelbach JI, Mansour WY, Zielinski A, Petersen C, Clauditz TS, Münscher A, Friedl AA and Borgmann K: PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response. Oncotarget. 7:9732–9741. 2016.PubMed/NCBI View Article : Google Scholar

24 

Shimura T, Kakuda S, Ochiai Y, Nakagawa H, Kuwahara Y, Takai Y, Kobayashi J, Komatsu K and Fukumoto M: Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression. Oncogene. 29:4826–4837. 2010.PubMed/NCBI View Article : Google Scholar

25 

Wang Z, Zuo W, Zeng Q, Li Y, Lu T, Bu Y and Hu G: The homologous recombination repair pathway is associated with resistance to radiotherapy in nasopharyngeal carcinoma. Int J Biol Sci. 16:408–419. 2020.PubMed/NCBI View Article : Google Scholar

26 

Bakhoum SF and Cantley LC: The multifaceted role of chromosomal instability in cancer and its microenvironment. Cell. 174:1347–1360. 2018.PubMed/NCBI View Article : Google Scholar

27 

Kuwahara Y, Roudkenar MH, Urushihara Y, Saito Y, Tomita K, Roushandeh AM, Sato T, Kurimasa A and Fukumoto M: X-ray induced mutation frequency at the Hypoxanthine Phosphoribosyltransferase locus in clinically relevant radioresistant cells. Int J Med Phs Clin Eng Radiat Oncol. 6:377–391. 2017.

28 

Ceccaldi R, Rondinelli B and D'Andrea AD: Repair pathway choices and consequences at the double-strand break. Trends Cell Biol. 26:52–64. 2016.PubMed/NCBI View Article : Google Scholar

29 

Schurmann L, Schumacher L, Roquette K, Brozovic A and Fritz G: Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways. Cancer Lett. 520:361–373. 2021.PubMed/NCBI View Article : Google Scholar

30 

Lindemann A, Patel AA, Tang L, Tanaka N, Gleber-Netto FO, Bartels MD, Wang L, McGrail DJ, Lin SY, Frank SJ, et al: Combined Inhibition of Rad51 and wee1 enhances cell killing in HNSCC through induction of apoptosis associated with excessive DNA damage and replication stress. Mol Cancer Ther. 20:1257–1269. 2021.PubMed/NCBI View Article : Google Scholar

31 

Sak A, Stueben G, Groneberg M, Bocker W and Struschke M: Targeting of Rad51-dependent homologous recombination: Implications for the radiation sensitivity of human lung cancer cell lines. Br J Cancer. 92:1089–1097. 2005.PubMed/NCBI View Article : Google Scholar

32 

Wéra AC, Lobbens A, Stoyanov M, Lucas S and Michiels C: Radiation-induced synthetic lethality: Combination of poly(ADP-ribose) polymerase and RAD51 inhibitors to sensitize cells to proton irradiation. Cell Cycle. 18:1770–1783. 2019.PubMed/NCBI View Article : Google Scholar

33 

Mirzayans R and Murray D: Intratumor heterogeneity and therapy resistance: Contributions of dormancy, apoptosis reversal (anastasis) and cell fusion to disease recurrence. Int J Mol Sci. 21(1308)2020.PubMed/NCBI View Article : Google Scholar

34 

Yanai M, Makino H, Ping B, Takeda K, Tanaka N, Sakamoto T, Yamaguchi K, Kodani M, Yamasaki A, Igishi T and Shimizu E: DNA-PK inhibition by NU7441 enhances chemosensitivity to topoisomerase inhibitor in non-small cell lung carcinoma cells by blocking DNA damage repair. Yonago Acta Med. 60:9–15. 2017.PubMed/NCBI

35 

Zhu J, Zhou L, Wu G, Konig H, Lin X, Li G, Qiu XL, Chen CF, Hu CM, Goldblatt E, et al: A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. EMBO Mol Med. 5:353–365. 2013.PubMed/NCBI View Article : Google Scholar

36 

Groth P, Orta ML, Elvers I, Majumder MM, Lagerqvist A and Helleday T: Homologous recombination repairs secondary replication induced DNA double-strand breaks after ionizing radiation. Nucleic Acids Res. 40:6585–6594. 2012.PubMed/NCBI View Article : Google Scholar

37 

Yue X, Bai C, Xie D, Ma T and Zhou PK: DNA-PKcs: A multi-faceted player in DNA damage response. Front Genet. 11(607428)2020.PubMed/NCBI View Article : Google Scholar

38 

Shibata A, Conrad S, Birraux J, Geuting V, Barton O, Ismail A, Kakarougkas A, Meek K, Taucher-Scholz G, Löbrich M and Jeggo PA: Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO J. 30:1079–1092. 2011.PubMed/NCBI View Article : Google Scholar

39 

Frankenberg-Schwager M, Gebauer A, Koppe C, Wolf H, Pralle E and Frankenberg D: Single-strand annealing, conservative homologous recombination, nonhomologous DNA end joining, and the cell cycle-dependent repair of DNA double-strand breaks induced by sparsely or densely ionizing radiation. Radiat Res. 171:265–273. 2009.PubMed/NCBI View Article : Google Scholar

40 

Barazas M, Gasparini A, Huang Y, Küçükosmanoğlu A, Annunziato S, Bouwman P, Sol W, Kersbergen A, Proost N, de Korte-Grimmerink R, et al: Radiosensitivity is an acquired vulnerability of PARPi-resistant BRCA1-deficient tumors. Cancer Res. 79:452–460. 2019.PubMed/NCBI View Article : Google Scholar

41 

Zhang Z, Feng X, Deng Z, Chen J, Wang Y, Zhao M, Zhao Y, He S and Huang Q: Irradiation-induced polyploid giant cancer cells are involved in tumor cell repopulation via neosis. Mol Oncol. 15:2219–2234. 2021.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Ohuchi K, Saga R, Hasegawa K, Tsuruga E, Hosokawa Y, Fukumoto M and Okumura K: DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells. Biomed Rep 18: 28, 2023.
APA
Ohuchi, K., Saga, R., Hasegawa, K., Tsuruga, E., Hosokawa, Y., Fukumoto, M., & Okumura, K. (2023). DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells. Biomedical Reports, 18, 28. https://doi.org/10.3892/br.2023.1610
MLA
Ohuchi, K., Saga, R., Hasegawa, K., Tsuruga, E., Hosokawa, Y., Fukumoto, M., Okumura, K."DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells". Biomedical Reports 18.4 (2023): 28.
Chicago
Ohuchi, K., Saga, R., Hasegawa, K., Tsuruga, E., Hosokawa, Y., Fukumoto, M., Okumura, K."DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells". Biomedical Reports 18, no. 4 (2023): 28. https://doi.org/10.3892/br.2023.1610
Copy and paste a formatted citation
x
Spandidos Publications style
Ohuchi K, Saga R, Hasegawa K, Tsuruga E, Hosokawa Y, Fukumoto M and Okumura K: DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells. Biomed Rep 18: 28, 2023.
APA
Ohuchi, K., Saga, R., Hasegawa, K., Tsuruga, E., Hosokawa, Y., Fukumoto, M., & Okumura, K. (2023). DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells. Biomedical Reports, 18, 28. https://doi.org/10.3892/br.2023.1610
MLA
Ohuchi, K., Saga, R., Hasegawa, K., Tsuruga, E., Hosokawa, Y., Fukumoto, M., Okumura, K."DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells". Biomedical Reports 18.4 (2023): 28.
Chicago
Ohuchi, K., Saga, R., Hasegawa, K., Tsuruga, E., Hosokawa, Y., Fukumoto, M., Okumura, K."DNA‑PKcs phosphorylation specific inhibitor, NU7441, enhances the radiosensitivity of clinically relevant radioresistant oral squamous cell carcinoma cells". Biomedical Reports 18, no. 4 (2023): 28. https://doi.org/10.3892/br.2023.1610
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team